Detalhe da pesquisa
1.
Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.
J Oncol Pharm Pract
; 28(1): 215-221, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34134568
2.
Clinical features and prognostic significance of splenic involvement in sarcoidosis.
Monaldi Arch Chest Dis
; 87(3): 893, 2017 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29424195
3.
Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study.
J Chemother
; : 1-7, 2024 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38904164
4.
Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study.
J Chemother
; : 1-7, 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38497444
5.
The use of bevacizumab in primary malignant tumors of the central nervous system: A single-center experience.
Medicine (Baltimore)
; 102(30): e34286, 2023 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37505182
6.
Clinical course and features of soft tissue sarcomas in geriatric patients: a single-center experience.
J Int Med Res
; 51(3): 3000605231159319, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36879483
7.
Comparison of second-line treatments in metastatic renal cell carcinoma patients: A single-center experience.
Medicine (Baltimore)
; 102(41): e35245, 2023 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37832108